Clinical Trials Browser

INDUSTRY × Breast Neoplasms × balixafortide × Clear all

NCT03786094 2023-11-01

FORTRESS

Phase 3 Terminated

432 enrolled 13 charts

Breast Neoplasms

NCT01837095 2018-09-14

Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms